Cargando…

PD-L1 expression in EBV associated gastric cancer: a systematic review and meta-analysis

OBJECTIVES: The aim of this systematic review and meta-analysis is to the summarize the evidence on programmed cell death protein ligand 1 (PD-L1) in Epstein-Barr virus associated gastric cancer (EBVaGC) and to estimate the expression rate of PD-L1 among this subtype of Gastric Cancer (GC). MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lima, Áurea, Sousa, Hugo, Medeiros, Rui, Nobre, Amanda, Machado, Manuela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941030/ https://www.ncbi.nlm.nih.gov/pubmed/35318527 http://dx.doi.org/10.1007/s12672-022-00479-0

Ejemplares similares

The Impact of COVID-19 Pandemic in Portuguese Cancer Patients: A Retrospective Study
por: Lima, Aurea, et al.
Publicado: (2021)

PTEN Expression Was Significantly Associated with PD-L1 Score but Not with EBV Infection in Gastric Cancer
por: Cao, Donghui, et al.
Publicado: (2022)

EBV(+) and MSI Gastric Cancers Harbor High PD-L1/PD-1 Expression and High CD8(+) Intratumoral Lymphocytes
por: De Rosa, Simona, et al.
Publicado: (2018)

PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms
por: Nakano, Hiroshi, et al.
Publicado: (2021)

Prognostic Implication of EBV Infection in Gastric Carcinomas: A Systematic Review and Meta-Analysis
por: Pyo, Jung-Soo, et al.
Publicado: (2023)

PTEN Protein Loss and Loss-of-Function Mutations in Gastric Cancers: The Relationship with Microsatellite Instability, EBV, HER2, and PD-L1 Expression
por: Kim, Binnari, et al.
Publicado: (2020)

Clinicopathological features of PD-L1 protein expression, EBV positivity, and MSI status in patients with advanced gastric and esophagogastric junction adenocarcinoma in Japan
por: Yoshida, Tsutomu, et al.
Publicado: (2022)

PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications
por: Xing, Wei, et al.
Publicado: (2016)

The EBV Gastric Cancer Resource (EBV-GCR): A Suite of Tools for Investigating EBV-Associated Human Gastric Carcinogenesis
por: Salnikov, Mikhail Y., et al.
Publicado: (2023)

PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis
por: Gu, Lihu, et al.
Publicado: (2017)

EBV and MSI Status in Gastric Cancer: Does It Matter?
por: do Nascimento, Catarina Neto, et al.
Publicado: (2022)

Role of Key TYMS Polymorphisms on Methotrexate Therapeutic Outcome in Portuguese Rheumatoid Arthritis Patients
por: Lima, Aurea, et al.
Publicado: (2014)

PD-L1 predicts poor prognosis for nasopharyngeal carcinoma irrespective of PD-1 and EBV-DNA load
por: Zhou, Yajuan, et al.
Publicado: (2017)

The role of EBV-encoded miRNA in EBV-associated gastric cancer
por: Liu, Ting, et al.
Publicado: (2023)

Differential expression of EBV proteins LMP1 and BHFR1 in EBV-associated gastric and nasopharyngeal cancer tissues
por: WANG, AILIANG, et al.
Publicado: (2016)

The predictive value of PD‐L1 expression in patients with advanced hepatocellular carcinoma treated with PD‐1/PD‐L1 inhibitors: A systematic review and meta‐analysis
por: Yang, Yao, et al.
Publicado: (2023)

Clinicopathological Significance of EBV-Infected Gastric Carcinomas: A Meta-Analysis
por: Pyo, Jung-Soo, et al.
Publicado: (2020)

Partial absence of PD‐1 expression by tumor‐infiltrating EBV‐specific CD8(+) T cells in EBV‐driven lymphoepithelioma‐like carcinoma
por: Simoni, Yannick, et al.
Publicado: (2020)

PD-L1 and EBV LMP1 expressions in classic Hodgkin lymphomas and its correlation with clinicopathological parameters and prognosis
por: ÖZDEMİR, Süleyman, et al.
Publicado: (2022)

The Anti-PD-1/PD-L1 Immunotherapy for Gastric Esophageal Cancer: A Systematic Review and Meta-Analysis and Literature Review
por: Chen, Ke, et al.
Publicado: (2021)

IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma
por: Moon, Ji Wook, et al.
Publicado: (2017)

Prediction of Methotrexate Clinical Response in Portuguese Rheumatoid Arthritis Patients: Implication of MTHFR rs1801133 and ATIC rs4673993 Polymorphisms
por: Lima, Aurea, et al.
Publicado: (2014)

A Systematic Review and Meta-analysis of PD-1 and PD-L1 Inhibitors Monotherapy in Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
por: Voutsadakis, Ioannis A
Publicado: (2020)

Analysis of Epstein–Barr Virus (EBV) and PD-L1 Expression in Nasopharyngeal Carcinoma Patients in a Non-Endemic Region
por: Dias, Josiane M., et al.
Publicado: (2022)

PD-L1 Expression in Cutaneous Angiosarcomas: A Systematic Review with Meta-Analysis
por: Lobrano, Renato, et al.
Publicado: (2023)

Prognostic significance of PD-L1 expression in patients with gastric cancer in East Asia: a meta-analysis
por: Liu, Yong-Xuan, et al.
Publicado: (2016)

Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study)
por: Alberti, Andrea, et al.
Publicado: (2023)

Appropriate PD-L1 Cutoff Value for Gastric Cancer Immunotherapy: A Systematic Review and Meta-Analysis
por: Xie, Tong, et al.
Publicado: (2021)

Adenosine Induces EBV Lytic Reactivation through ADORA1 in EBV-Associated Gastric Carcinoma
por: Choi, Su Jin, et al.
Publicado: (2019)

EBV Positive Gastric Carcinomas and Their Clinicopathological Characteristics
por: Ognjenovic, Ljubomir, et al.
Publicado: (2018)

PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival
por: Fang, Wenfeng, et al.
Publicado: (2015)

Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer
por: Imai, Yushi, et al.
Publicado: (2020)

PD-L1 is upregulated in CD163+ tonsillar macrophages from children undergoing EBV primary infection
por: Moyano, Agustina, et al.
Publicado: (2022)

The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis
por: Huang, Zi-Lu, et al.
Publicado: (2019)

The Value of PD-L1 Expression in Predicting the Efficacy of Anti-PD-1 or Anti-PD-L1 Therapy in Patients with Cancer: A Systematic Review and Meta-Analysis
por: Chen, Xiao-Jiang, et al.
Publicado: (2020)

Prognostic Epstein-Barr Virus (EBV) miRNA biomarkers for survival outcome in EBV-associated epithelial malignancies: Systematic review and meta-analysis
por: Abusalah, Mai Abdel Haleem, et al.
Publicado: (2022)

PD-1 and PD-L1 co-expression predicts favorable prognosis in gastric cancer
por: Wu, Yanhua, et al.
Publicado: (2017)

PD-1 and LAG-3 expression in EBV-associated pediatric Hodgkin lymphoma has influence on survival
por: Jimenez, Oscar, et al.
Publicado: (2022)

Epstein–Barr Virus (EBV) Genotypes Associated with the Immunopathological Profile of People Living with HIV-1: Immunological Aspects of Primary EBV Infection
por: Pereira, Leonn Mendes Soares, et al.
Publicado: (2022)

Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
por: Shen, Xian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vlbbfgu5aj1s06047r3q61sqig